GlassScriptPhysician profile
Andrew Y Kee
NPI 1043299217
$7,170.15
in general payments reported to CMS, 2019-2025
7 companies · $4,289 in 2025
The $4,289 reported for 2025 was more than what 94% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2021: $1,890 · 2022: $351 · 2023: $159 · 2024: $357 · 2025: $4,289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,589 · Food and Beverage: $1,217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,589.35 |
| Food and Beverage | $1,216.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elekta, INC. | $4,780.67 | 2019-2025 | Leksell Gamma Knife Icon, Elekta Medical Linear Accelerator, Elekta Unity |
| Astrazeneca Pharmaceuticals LP | $1,890.00 | 2021 | |
| Boston Scientific Corporation | $194.99 | 2024 | Spaceoar Vue System - 10ml |
| Atricure, INC. | $135.03 | 2022-2023 | |
| Springworks Therapeutics, INC. | $125.00 | 2025 | |
| Reflexion Medical, INC. | $23.46 | 2023 | Reflexion Medical Radiotherapy System |
| Varian Medical Systems, INC. | $21.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Kee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.